Who Paid My Doc
Paul Dasari
Pediatric Endocrinology Oklahoma City, OK Medical Doctor
NPI 1376709816 CMS profile 402122
1200 Everett Dr Fl 10, Oklahoma City, OK 73104
General payments
$1,049
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Paul Dasari of Oklahoma City, OK is reported in the CMS Open Payments database as having received $1,049 across 11 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 55th percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $521 | 3 | |
| 2024 | General | $102 | 5 | |
| 2023 | General | $35 | 1 | |
| 2021 | General | $380 | 1 | |
| 2019 | General | $11 | 1 |
Beside peers
- Paul Dasari
- Pediatric Endocrinology median
- Middle half of Pediatric Endocrinology
- National median
In program year 2025, general payments to Paul Dasari were reported at $521. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.
Show as a table
| Year | Paul Dasari | Pediatric Endocrinology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $11 | $196 | $68–$845 | $163 |
| 2020 | $0 | $124 | $37–$722 | $114 |
| 2021 | $380 | $134 | $35–$691 | $132 |
| 2022 | $0 | $177 | $47–$726 | $149 |
| 2023 | $35 | $236 | $75–$887 | $160 |
| 2024 | $102 | $259 | $91–$979 | $164 |
| 2025 | $521 | $293 | $106–$1,640 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
11 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Endocrinology in Oklahoma
Steven Chernausek
Pediatric Endocrinology · Oklahoma City, OK
Ankur Rughani
Pediatric Endocrinology · Oklahoma City, OK
Kenneth Copeland
Pediatric Endocrinology · Oklahoma City, OK
Rebecca Schaub
Pediatric Endocrinology · Oklahoma City, OK
Shelly Mercer
Pediatric Endocrinology · Tulsa, OK
David Sparling
Pediatric Endocrinology · Oklahoma City, OK
Related records
Pediatric Endocrinology in Oklahoma
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Endocrinology
Everyone recorded under this specialty, nationwide.
Doctors in Oklahoma
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.